Second Genome Appoints Matthew W. McClure, M.D., as Chief Medical Officer

March 5, 2018, South San Francisco, CA March 5, 2018

Read More

Second Genome Strengthens R&D Program in Immuno-Oncology with Four Academic Collaborations

February 28, 2018, Feb. 28, 2018

Read More

Second Genome Advances Lead, Oral Small Molecule SGM-1019, Toward Clinical Investigation in NASH After Demonstrating Safety and Tolerability in Phase 1 Study

December 19, 2017, SOUTH SAN FRANCISCO, Calif., Dec 19, 2018

Read More

Second Genome Launches Study of the Relationship Between Microbiome and Central Nervous System in Autism Spectrum Disorders

October 3, 2017,

Fast-Track SBIR grant applied towards the development of a commercial platform for discovery and validation of key microbial metabolites linked to CNS disorders

Read More

Second Genome Named Technology Pioneer by World Economic Forum

June 4, 2017,

Read More

Second Genome Announces Appointments in Human Resources, Finance to Support Corporate Growth

December 7, 2016, South San Francisco, CA

Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, announced today that it has appointed Jim Sjoerdsma as executive vice president of human resources and Brian Dowd as senior vice president of finance.

Read More

Second Genome Partners with King’s College London to Evaluate the Influence of the Microbiome in Landmark EAT Study

October 11, 2016, South San Francisco, CA

Read More

Monsanto Collaborates with Second Genome to use Microbiome Technology Platform to Accelerate Protein Discovery

September 6, 2016, St. Louis, MO and South San Francisco, CA

Microbial genome analysis using big data science, bioinformatics and machine learning expected to drive discovery of microbiome-based solutions that can help farmers better manage on-farm challenges

Read More